小眼球“转动”大产业——中国眼谷打造科技创新新“视”界

Core Insights - The article highlights the significant advancements and innovations emerging from the China Eye Valley, a pioneering hub for eye health technology and industry development in Wenzhou, Zhejiang, China [1][2][3][4] Group 1: Innovations and Achievements - China Eye Valley is home to groundbreaking technologies, including the world's first nasal-retinal microsurgery navigation system and the first artificial retinal medical chip company [1] - The introduction of a 0.01% low-concentration atropine eye drop has gained popularity among parents for its effectiveness in slowing myopia progression, with the product receiving regulatory approval as the world's first myopia prevention drug [2] Group 2: Ecosystem and Collaboration - The success of China Eye Valley is attributed to its comprehensive innovation ecosystem, which includes national key laboratories and clinical research centers, fostering collaboration among scientists and industry players [3] - Since its establishment, China Eye Valley has formed partnerships with over 420 companies and has co-built 42 research institutes with major corporations like Huawei and BOE [3] Group 3: Future Directions - The leadership at China Eye Valley aims to enhance the innovation environment by improving policies, funding, and support systems to attract more companies to develop technologies and pharmaceuticals that meet patient needs [4]